SXTPW

60 Degrees Pharm

• TipRanks·5d ago

  60 Degrees updates strategy for ARAKODA and profitability

• TipRanks·07/09 20:31

  Interim Trial Plan Finalized for Tafenoquine Babesiosis Study

• NASDAQ·07/09 08:14

  60 Degrees Pharma Signs FSU Deal To Advance Castanospermine For Tick-Borne Diseases

• TipRanks·07/08 13:20

  60 Degrees Pharmaceuticals signs option deal with Florida State University

• Benzinga·07/08 12:08

  60 Degrees Pharmaceuticals Enters Exclusive Option Agreement With Florida State's Research Foundation Regarding IP To Develop Castanospermine For Multiple Tick-Borne Diseases

• Reuters·07/08 12:01

  60 DEGREES PHARMACEUTICALS ANNOUNCES EXCLUSIVE OPTION AGREEMENT WITH FLORIDA STATE UNIVERSITY TO ADVANCE CASTANOSPERMINE FOR TICK-BORNE DISEASES

• NASDAQ·07/02 07:49

  60 Degrees' Phase 2 B-Free Babesiosis Study Of ARAKODA Clears Safety Board Review

• TipRanks·07/01 12:25

  60 Degrees Pharmaceuticals announces DSMB recommendation for B-Free study

• PUBT·07/01 12:21

  60 Degrees Pharma says DSMB backs continuing Phase 2 tafenoquine chronic babesiosis fatigue study

• Benzinga·07/01 12:08

  60 Degrees Pharma's B-Free Babesiosis Trial Clears Initial Safety Review, Advances After DSMB Recommendation

• Reuters·07/01 12:02

  60 DEGREES PHARMACEUTICALS ANNOUNCES POSITIVE RECOMMENDATION FROM DATA SAFETY MONITORING BOARD FOR B-FREE PHASE 2 STUDY OF TAFENOQUINE FOR TREATMENT OF CHRONIC BABESIOSIS PATIENTS WITH SEVERE FATIGUE

• Benzinga·06/16 21:06

  12 Health Care Stocks Moving In Tuesday's After-Market Session

• TipRanks·06/16 02:05

  Top Executive Makes Bold Move With Fresh Buy in Pharma Stock

• PUBT·06/15 20:51

  60 Degrees Pharma CEO Geoffrey Dow acquires 7,350 common shares worth $10,130.24

• Seeking Alpha·06/11 13:22

  60 Degrees Pharmaceuticals sings FSU deal to scale Australian chestnut extract